CPRX’s Director, Harper Molly, sellss 14,000 shares.

Catalyst Pharmaceuticals Inc’s filing revealed that its Director Harper Molly unloaded Company’s shares for reported $0.2 million on Dec 15 ’23. In the deal valued at $14.39 per share,14,000 shares were sold. As a result of this transaction, Harper Molly now holds 0 shares worth roughly $0.0. Then, Tierney David S sold 50,000 shares, generating […]

Catalyst Pharmaceuticals Inc [CPRX] Insider Harper Molly sells 14,000 Shares

Catalyst Pharmaceuticals Inc’s recently made public that its Director Harper Molly unloaded Company’s shares for reported $0.2 million on Dec 15 ’23. In the deal valued at $14.39 per share,14,000 shares were sold. As a result of this transaction, Harper Molly now holds 0 shares worth roughly $0.0. Then, Tierney David S sold 50,000 shares, […]

CPRX short interest jump by 27.51%, reflecting negative sentiment

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals Inc shares valued at $201,420 were sold by Harper Molly on Dec 15 ’23. At $14.39 per share, Harper Molly sold 14,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the […]

Recent Insider Activity Could Benefit Catalyst Pharmaceuticals Inc (CPRX)

Catalyst Pharmaceuticals Inc’s recently made public that its Director Harper Molly unloaded Company’s shares for reported $0.2 million on Dec 15 ’23. In the deal valued at $14.39 per share,14,000 shares were sold. As a result of this transaction, Harper Molly now holds 0 shares worth roughly $0.0. Then, Tierney David S sold 50,000 shares, […]

Catalyst Pharmaceuticals Inc [CPRX] Insider Selling: Time to sell?

Catalyst Pharmaceuticals Inc’s recently made public that its Director Harper Molly unloaded Company’s shares for reported $0.2 million on Dec 15. In the deal valued at $14.39 per share,14,000 shares were sold. As a result of this transaction, Harper Molly now holds 0 shares worth roughly $0.0. Then, Tierney David S sold 50,000 shares, generating […]

Sharp decrease in CPRX’s short interest leads to decline in days-to-cover ratio

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals Inc shares valued at $201,420 were sold by Harper Molly on Dec 15. At $14.39 per share, Harper Molly sold 14,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion […]

CPRX stock rated an Outperform by Oppenheimer

In a filing, Catalyst Pharmaceuticals Inc revealed its Director Harper Molly unloaded Company’s shares for reported $0.2 million on Dec 15. In the deal valued at $14.39 per share,14,000 shares were sold. As a result of this transaction, Harper Molly now holds 0 shares worth roughly $0.0. Then, Tierney David S sold 50,000 shares, generating […]